Cataracts, dry eyes, glaucoma and other eye problems become more common with age. But these can be treated — and sometimes ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic macular edema (DME) who have previously responded to at least 2 ...

Eye injections are a treatment, not a cure for this condition, and patients often need frequent injections to maintain their vision. While a diagnosis of macular degeneration can seem scary ...

it is possible that patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of pharmacologic therapy, including intravitreal injections of anti-VEGF ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

The Food and Drug Administration (FDA) has expanded the labeling for Izervay™ (avacincaptad pegol intravitreal solution) to include longer-term ...

It included a woman in her 50s who lost sight in one eye just a day after her first semaglutide injection ... 60s developed blurred vision and retinal bleeding 10 months into treatment, later ...

Wet age-related macular degeneration threatens central ... The main treatment involves eye injections of anti-VEGF drugs to stop problematic blood vessel growth. Options include aflibercept ...

Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Recent reports link weight loss drugs Ozempic and Mounjaro to severe vision loss. With cases of blindness emerging, medical ...

Last year, the American Academy of Ophthalmology recommended that patients experiencing vision problems while taking semaglutide stop using the drug and consult a physician.